Global Single Cell Genome Sequencing Market Outlook 2028

  • Product Code:
    RP-ID-10335698
  • Published Date:
    30 Sep 2020
  • Region:
    Global
  • Pages:
    140
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:
    Pub-ID-9

Impact Analysis on the Growth of Market

Activating Probable Propositions Amidst COVID-19 Crisis

With things going haywire, we analyze key points to make sure that the businesses around the globe are completely prepared to tackle potential implications caused by COVID-19. Be it protecting employees, customers or the overall business operations, we ensure that the employers take the right decisions, make strategic investments and maintain a healthy work culture along with taking probable measures to minimize the financial loss. Know More

Global Single Cell Genome Sequencing Market

The single cell genome sequencing market is anticipated to grow in upcoming years on the back of rising prevalence of the genetic disorders, increasing demand for targeted sequencing technologies, and recent advancement in DNA sequencing technology around the globe. The market garnered revenue of USD 1,133.48 million in 2019 and is estimated to touch USD 4,405.78 million by 2028, by registering a CAGR of 16.25% over the forecast period, i.e., 2021-2028. Rising healthcare expenditure, increasing R&D activities coupled with growing development in the Next Generation Sequencing (NGS) technology are some of the major indicators driving the market growth. However, stringent government regulations pertaining to single cell genome sequencing technology might negatively affect the market growth.
In terms of market segmentation, the global single cell genome sequencing market is segmented by product, application, end-user and by region. Regionally, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa, out of which, the market in North America accounted for leading share (42.31%) in 2019 owing to rising number of disease indications needing genetic screening. The market is bifurcated into reagents and instruments based on the product segment. Among these segments, instruments segment is estimated to attain a CAGR of around 15% over the forecast period.
Some of the leading market players in the global single cell genome sequencing market are Qiagen, F. Hoffmann-La Roche Ltd., Agilent Technologies, Inc., Thermo Fisher Scientific, Illumina, Inc., Bio-Rad Laboratories, Inc., Oxford Nanopore Technologies, Pacific Biosciences of California, Inc., and Novogene Co., Ltd.

Global Single Cell Genome Sequencing Market


1. INTRODUCTION
1.1. MARKET DEFINITION
1.2. PRODUCT OVERVIEW
2. ASSUMPTIONS AND ACRONYMS
3. RESEARCH METHODOLOGY
4. EXECUTIVE SUMMARY - GLOBAL SINGLE CELL GENOME SEQUENCING MARKET
5. MARKET DYNAMICS
5.1. GROWTH DRIVERS
5.2. KEY TRENDS
5.3. KEY MARKET OPPORTUNITIES
5.4. MAJOR ROADBLOCKS FOR THE MARKET GROWTH
6. INDUSTRY RISK ANALYSIS
6.1. DEMAND RISK ANALYSIS
6.2. SUPPLY RISK ANALYSIS
7. EVALUATION ON THE IMPACT OF COVID-19 ON THE GLOBAL SINGLE CELL GENOME SEQUENCING MARKET
8. GLOBAL SINGLE CELL GENOME SEQUENCING MARKET
8.1. MARKET SIZE (USD MILLION), 2018-2028
V SEGMENTATION BY PRODUCT
· REAGENTS AND INSTRUMENTS: NEXT GENERATION SEQUENCING SYSTEMS, PCR INSTRUMENTS, MICROARRAYS AND OTHERS, MARKET SIZE (USD MILLION), 2018-2028
V SEGMENTATION BY APPLICATION
· PRE-SEQUENCING, SEQUENCING AND DATA ANALYSIS, MARKET SIZE (USD MILLION), 2018-2028
V SEGMENTATION BY END USER
· HOSPITALS, CLINICS, RESEARCH & ACADEMIC INSTITUTIONS AND BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, MARKET SIZE (USD MILLION), 2018-2028
V SEGMENTATION BY REGION
· NORTH AMERICA SINGLE CELL GENOME SEQUENCING MARKET OUTLOOK
· EUROPE SINGLE CELL GENOME SEQUENCING MARKET OUTLOOK
· ASIA PACIFIC SINGLE CELL GENOME SEQUENCING MARKET OUTLOOK
· LATIN AMERICA SINGLE CELL GENOME SEQUENCING MARKET OUTLOOK
· MIDDLE EAST & AFRICA SINGLE CELL GENOME SEQUENCING MARKET OUTLOOK
9. COMPETITIVE LANDSCAPE
V MARKET SHARE ANALYSIS BY MANUFACTURER
V COMPANY PROFILES
· QIAGEN
· F. HOFFMANN-LA ROCHE LTD
· AGILENT TECHNOLOGIES, INC.
· THERMO FISHER SCIENTIFIC
· ILLUMINA, INC
· BIO-RAD LABORATORIES, INC.
· OXFORD NANOPORE TECHNOLOGIES
· PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
· NOVOGENE CO., LTD.
10. STRATEGIC RECOMMENDATIONS

Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Qiagen, F. Hoffmann-La Roche Ltd., Agilent Technologies, Inc., Thermo Fisher Scientific, Illumina, Inc., Bio-Rad Laboratories, Inc., Oxford Nanopore Technologies, Pacific Biosciences of California, Inc., and Novogene Co., Ltd.

Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports